BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAIQ)

CUSIP: 09075P204

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 5 signals
Share change
-310,194
SEC-reported price per share
$0.06
Number of holders
2
Value change
-$421,421
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
32,499,319

Security key

09075P204

Report period

Q3 2026

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of BTAIQ - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
INTEGRATED CORE STRATEGIE...
Disclosed value leader
Rashmi Agarwal
Comparable rows
4/15
Latest evidence
30 Jun 2026
13D/G 3/4/5 Lead comparable stake: 8.4% 11 rows are not safely comparable across share classes. 13D/G row: INTEGRATED CORE STRATEGIES (US) LLC Showing 1-6 of 15 holder rows.

Quick read

INTEGRATED CORE STRATEGIES (US) LLC leads the comparable SEC ownership view at 8.4%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INTEGRATED CORE STRATEGIES (US) LLC's linked filing trail.
Comparable ownership Top 4
INTEGRATED CORE STRATEGIES (US) LLC 8.4%
ARMISTICE CAPITAL, LLC 5%
Oaktree Capital Group Holdings GP... 2.7%
Qatar Investment Authority 0.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
Millennium Management LLC
8.4%
Reported 13D/G · 31 Dec 2025
$3,762,144
1,835,192 shares
+$1,654,635 31 Dec 2025
ARMISTICE CAPITAL, LLC
13D/G
5%
Reported 13D/G · 30 Jun 2026
$1,427,110
1,621,716 shares
+$1,173,555 30 Jun 2026
Oaktree Capital Group Holdings GP, LLC
13D/G
Oaktree Capital Holdings, LLC
2.7%
Reported 13D/G · 31 Mar 2025
$28,939
170,230 shares
-$434,154 31 Mar 2025
Qatar Investment Authority
13D/G
0.6%
Reported 13D/G · 31 Dec 2025
$26,531
156,066 shares
-$436,562 31 Dec 2025
Rashmi Agarwal
3/4/5
10%+ Owner
—
denominator unverified
$187,267,747
8,554,945 shares
— 03 Apr 2023
Vipin Agarwal
3/4/5
10%+ Owner
—
denominator unverified
$187,267,747
8,554,945 shares
— 03 Apr 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
38
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
47
Q3 2026 holders
2
Holder diff
-45
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .